MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2026 International Congress

    Assessing The Role Of Afg3l2 Pathogenic Variants In Parkinson’s Disease

    V. Quintana-Peña, I. Keller Sarmiento, B. Bustos, L. Lange, K. Lohmann, R. Alcalay, M. Marti, N. Okubadejo, S. Lim, T. Foroud, R. Kaiyrzhanov, E. Valente, R. Krüger, H. Morris, B. Jeon, C. Klein, J. Trinh, N. Mencacci (Chicago, USA)

    Objective: The aim of this study is to investigate the potential link between AFG3L2 rare pathogenic/likely pathogenic variants with Parkinson’s disease (PD). Background: AFG3L2 is…
  • 2026 International Congress

    Markerless Kinematic Analysis of Gait and Turning in Parkinson’s Disease

    A. Tahara, A. Chinaglia, R. Monteiro, L. Santos, P. Santiago (Ribeirão Preto, Brazil)

    Objective: To investigate gait and turning biomechanics in individuals with Parkinson’s disease using a 3D markerless motion capture system following a dry needling intervention. Background:…
  • 2026 International Congress

    PEST-PD: Preliminary Findings from an Ongoing Longitudinal Observational Study for Prodromal Parkinson’s disease in farmers exposed to pesticides.

    E. Cubo, L. Gomez-Cuadrado, D. Garcia-Garcia, A. Canepa, B. Alonzo-Nuñez, D. de Lara (Burgos, Spain)

    Objective: To compare the risk for prodromal Parkinson's disease (PD) in subjects exposed and non-exposed to pesticides Background: Farmers may have an elevated risk of…
  • 2026 International Congress

    GBA1 deficiency promotes tau and TDP-43 co-pathology

    A. Park, L. Lee, M. Kim, M. Callier, E. Chiu, C. Latimer, M. Davis (Seattle, USA)

    Objective: To determine whether mutations in the gene beta-glucocerebrosidase 1 (GBA1), the strongest genetic risk factor for PD, promote tau and TDP-43 co-pathology alongside Lewy…
  • 2026 International Congress

    Utility of DaTscan in Children with suspected Juvenile Parkinsonism: A Single-Centre Cohort Study

    A. Spagarino, A. Salazar-Villacorta, A. Soo, J. Hassell, A. Notghi, L. Biassoni, M. Kurian (London, United Kingdom)

    Objective: To evaluate the utility of DaTscan imaging in a cohort of paediatric patients referred to a tertiary neurology centre (Great Ormond Street Hospital, GOSH).…
  • 2026 International Congress

    Sublingual apomorphine for parkinsonian tremor: Post-hoc analysis of pivotal trial data

    H. S Dafsari, J. Reis, K. Strauß, H. C Brigas, C. Denecke-Muhr, I. Pijuan Jiménez, J. Holenz (Cologne, Germany)

    Objective: We explored tremor outcomes associated with apomorphine sublingual film (SL‑APO) in patients with a tremor‑dominant PD phenotype. Background: Tremor is a common and disabling…
  • 2026 International Congress

    Ecological Momentary Assessment Monitoring Captures Motor Fluctuation Improvement after DBS in Parkinson’s Disease

    L. Drescher, J. Schikora, L. Feldmann, V. Witzig, P. Nonella, G. Brandt, GH. Schneider, J. Habets, A. Kühn (Berlin, Germany)

    Objective: To evaluate whether mobility measures based on ecological momentary assessment (EMAs) capture deep brain stimulation (DBS) motor improvement in Parkinson’s disease (PD) and correlate with clinician-rated motor impairment (UPDRS III) and motor…
  • 2026 International Congress

    Quantitative Changes in Speech After Focused Ultrasound Thalamotomy in Parkinson’s Disease and Essential Tremor

    P. Cortadi La-Villa, G. Diaz-Taveras, E. Salinas Jaime, M. šimek, E. Natera-Villalba, A. Martin-Bastida, L. Gonzalez-Quarante, A. Arcadi Da-Silva, C. Sanchez-Catasus, J. Rusz, M. Rodriguez-Oroz (Pamplona, Spain)

    Objective: To compare speech performance following unilateral MR-guided focused ultrasound (MRgFUS) targeting the ventral intermediate nucleus (VIM) of the thalamus in Parkinson’s disease (PD) and…
  • 2026 International Congress

    Motor outcomes and safety of staged bilateral MR-guided focused ultrasound subthalamotomy in Parkinson disease

    E. Navarro-Mocholí, R. Conde-Sardón, M. Campins-Romeu, I. Sastre-Bataller, M. Losada-López, C. Morata-Martínez, MJ. Ibáñez-Julià, MN. Afkir-Ortega, A. Lozano, A. Gutiérrez-Martín, I. Martínez-Torres (Valencia, Spain)

    Objective: To assess the 12-month efficacy and safety of staged bilateral STN-MRgFUS in patients with PD. Background: MR-guided focused ultrasound subthalamotomy (STN-MRgFUS) has emerged as…
  • 2026 International Congress

    Clinical study on acupuncture improving anxiety in Parkinson’s disease by regulating the HPA axis

    JQ. Fan, WJ. Lu, X. Liu, YT. Wang, LX. Zhuang (Guangzhou, China)

    Objective: To investigate the effect of acupuncture versus sham acupuncture for PDA. Background: Anxiety in PD (PDA) is identified by continuous feeling of worry, muscle tension,…
  • « Previous Page
  • 1
  • …
  • 185
  • 186
  • 187
  • 188
  • 189
  • …
  • 208
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley